SINTBILO® is the commercial brand name of Tafolecimab Injection, a fully human monoclonal antibody independently developed by Innovent Biologics. It specifically binds to PCSK9, blocks the interaction between PCSK9 and LDL receptors on hepatocytes, increases the quantity of LDL receptors…
This domestic generic product is marketed under the Chinese brand name Jianketuo®. Tobramycin Inhalation Solution is an inhaled aminoglycoside antibacterial drug. It exerts bactericidal effects by inhibiting bacterial protein synthesis, and high local drug concentration can be achieved in the…
Keluping® is the commercial brand name of Tunlametinib, a novel orally available MEK inhibitor independently developed in China. It selectively inhibits MEK1/2 kinase activity, blocks the MAPK signaling pathway, and suppresses the proliferation of tumor cells with relevant gene mutations.…
Synlian® is the commercial brand name of Linaprazan Glurate, a novel potassium-competitive acid blocker independently developed in China. It inhibits gastric acid secretion by reversibly blocking the potassium binding site of H+/K+-ATPase in gastric parietal cells, providing long-lasting acid suppression.…
Epidaza® is the commercial brand name of Chidamide, a novel orally active histone deacetylase inhibitor independently developed in China. It can selectively inhibit histone deacetylase, induce tumor cell apoptosis and cell cycle arrest, and exert anti-tumor effects. Main IndicationsFor the…
BILESSGLU® is the commercial brand name of Chiglitazar Sodium, a novel peroxisome proliferator-activated receptor (PPAR) pan-agonist developed domestically in China. It can activate PPARα, PPARγ and PPARδ receptors, improving insulin resistance and regulating glucose and lipid metabolism. Main IndicationsFor the…
Janumet XR® is the global commercial brand name, and Beilisu® is its Chinese brand name developed by Chiatai Tianqing. It is an oral fixed-dose combination tablet of sitagliptin (DPP-4 inhibitor) and extended-release metformin hydrochloride. Sitagliptin elevates active incretin hormone levels,…
Erbitux® is the commercial brand name of cetuximab, a chimeric mouse-human monoclonal antibody targeting epidermal growth factor receptor (EGFR) developed by Merck KGaA. It binds specifically to EGFR to block ligand-induced receptor activation, inhibiting tumour cell proliferation, invasion and metastasis.…
Erbitux® is the commercial brand name of cetuximab, a chimeric mouse-human monoclonal antibody targeting epidermal growth factor receptor (EGFR) developed by Merck KGaA. It binds specifically to EGFR to block ligand-induced receptor activation, inhibiting tumour cell proliferation, invasion and metastasis.…
Provocholine® is the commercial brand name of methacholine chloride, a direct‑acting cholinergic agonist developed by Methapharm Inc. It stimulates muscarinic receptors on bronchial smooth muscle to induce reversible bronchoconstriction, which is applied for bronchial provocation testing. Tianqing Suxin® is its…